14 episodes
TIMI Talks TIMI Study Group
-
- Health & Fitness
The TIMI Talks podcast provides a unique and trusted forum for engaging the cardiology community in the design, execution, and interpretation of randomized clinical trials. TIMI Talks will bring you expert roundtable discussions on the latest clinical trials, cardiology meeting recaps, as well as feature discussions on statistical considerations, new TIMI publications, and academic career development.
-
S2E6 – ACC 24 Scientific Sessions Preview with Dr. Doug Drachman
Dr. Douglas Drachman, Chair of the ACC Scientific Sessions, joins the podcast to preview highlights of the upcoming ACC and to share tips and advice on getting the most out of the conference.
-
S2E5 – Angina management and the ORBITA-2 trial with Dr. Rasha Al-Lamee
Dr Rasha Al-Lamee, Clinical Academic Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK, joins the podcast to discuss management of angina and the ORBITA trials.
-
S2E4 – Weight Loss Therapies and the SELECT Trial with Dr. Donna Ryan
Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial. Highlights TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | … Continue reading S2E4 – Weight Loss Therapies and the SELECT Trial with Dr. Donna Ryan
-
TIMI Talks S2E3 – Lp(a) therapies with Dr. Michelle O’Donoghue
TIMI Study Group senior investigator Dr. Michelle O’Donoghue joins the podcast to discuss Lp(a) therapies and the Ocean(a) trials.
-
TIMI Talks S2E2 – Factor XI Inhibition and AZALEA-TIMI 71 with Dr. Christian Ruff
Dr. Christian Ruff joins the podcast to discuss Factor XI inhibition and his recent Late-Breaking Clinical Trial presentation at AHA, the AZALEA-TIMI 71 trial.
-
TIMI Talks S2E1 – Iron Deficiency, Heart Failure, and the HEART-FID Trial with Dr. Rob Mentz
Dr. Rob Mentz premieres Season 2 and discusses his career and the results of the HEART-FID trial.